Preview

International Journal of Veterinary Medicine

Advanced search

Effectiveness of levofloxacin in experimental colibacillosis of laboratory animals and chickens

https://doi.org/10.17238/issn2072-2419.2021.1.62

Abstract

Herein we present a study on effectiveness of Levofloxacin in experimental colibacillosis of laboratory animals and chickens. The experiments were conducted in vivarium settings. In the course of the experiments we evaluated effectiveness of Levofloxacin administered in drinking water at different concentrations for treating laboratory animals and chickens which had been experimentally infected with Escherichia coli. For the first experiment white mice were divided into 7 groups, 40 per group. We began treat ing the mice with the antimicrobial at concentrations 300 mg, 200 mg, 100 mg, 50 mg and 25 mg Levofloxacin per l in drinking water in every group respectively 24 hours before the challenge with Escherichia coli in suspension at a dose of 1.5 x 10^7 CFUs. Levofloxacin was administered for 5 days. Analysing the outcome of the first experiment we concluded that satisfactory result was only achieved in the group of mice which had been prescribed Levofloxacin in drinking water at a concentration of 300 mg/ L for 5 days. The survival rate for this group was 65%. For those groups receiving Levofloxacin in drinking water at concentrations of 200 mg/L, 100 mg/L, 50 mg/L and 25 mg/L the desired effect was not achieved. For the second experiment we divided day-old Hisex Brown chicks into 7 groups (25 chickens per group). They began receiving Levofloxacin one day before the challenge with Escherichia coli in suspension at a dose of 3 x 10^8 CFUs. Group 1 received Levofloxacin in drinking water at a concentration of 25 mg/L for 5 days, Group 2 – 50 mg/L, Group 3 – 100 mg/L, Group 4 – 200 mg/L and Group 5 – 300 mg/L. Our research demonstrated that Levofloxacin, when administered in drinking water to challenged chickens at concentrations of 100 mg/L, 200 mg/L and 300 mg/L, has high therapeutic effectiveness (96%). Groups that received Levofloxacin at concentrations of 25 mg/L and 50 mg/L showed worse results. Thus, the survival rates were 64% and 80% respectively. The mortality rate in the control group was 84%.

About the Authors

A. D. Mazur
Belgorod Branch of FGBNU FNTs VIEV RAN (Federal State Budget Scientific Institution “Federal Scientific Centre – AllRussia Scientific Research Institute of Experimental Veterinary Medicine after K.I. Skryabin and Ya.R. Kovalenko of Russian Academy of Sciences”)
Russian Federation

junior research



V. N. Skvortsov
Belgorod Branch of FGBNU FNTs VIEV RAN (Federal State Budget Scientific Institution “Federal Scientific Centre – AllRussia Scientific Research Institute of Experimental Veterinary Medicine after K.I. Skryabin and Ya.R. Kovalenko of Russian Academy of Sciences”)
Russian Federation

Doctor of Veterinary Sciences, Head of Branch



D. V. Yurin
Belgorod Branch of FGBNU FNTs VIEV RAN (Federal State Budget Scientific Institution “Federal Scientific Centre – AllRussia Scientific Research Institute of Experimental Veterinary Medicine after K.I. Skryabin and Ya.R. Kovalenko of Russian Academy of Sciences”)
Russian Federation

Candidate of Veterinary Sciences, senior researcher



A. A. Moiseeva
Belgorod Branch of FGBNU FNTs VIEV RAN (Federal State Budget Scientific Institution “Federal Scientific Centre – AllRussia Scientific Research Institute of Experimental Veterinary Medicine after K.I. Skryabin and Ya.R. Kovalenko of Russian Academy of Sciences”)
Russian Federation

researcher



References

1. Андреева, Н.Л. Изучение бактериальных инфекций на птицефабриках (Ленинградская обл.) / Н.Л. Андреева, М.Е. Дмитриева, А.А. Климов, Л.С. Фогель // Ветеринария. – 2004. - №5. – С. 14- 16.

2. Антибиотики в птицеводстве: альтернативные методы профилактики заболеваний и лечения птицы / Э.Д. Джавадов, И.Н. Вихрева, Т.Т. Папазян [и др.] // Птицеводство. – 2017. – № 11. – С. 41-46.

3. Скворцов, В.Н. Антимикробная активность и лечебная эффективность норфлоксацина при экспериментальном колибактериозе цыплят / В. Н. Скворцов, В.В. Маханев, Д.В. Юрин // Ветеринарная патология. – 2012. – № 3 (41). – С. 68-72.

4. Джаилиди, Г.А. Анализ эпизоотического состояния птицеводства в Российской Федерации / Г.А. Джаилиди, А.Е. Лосаберидзе, А.А. Лысенко, Ю.Ю. Пономаренко // Ветеринария Кубани. – 2014. – №2. – С. 25-27.

5. Заикина, Е.Н. Эффективность ципрофлоксацина при экспериментальном колибактериозе цыплят / Е.Н. Заикина, В.Н. Скворцов, А.А. Балбуцкая// Международный вестник ветеринарии. – 2015. – №2. – С. 24-28.

6. Заикина, Е.Н. Лечение экспериментального колибактериоза цыплят / Е.Н. Заикина, В.Н. Скворцов, А.А. Балбуцкая// Международный вестник ветеринарии. – 2015. – №3. – С. 51-55.

7. Лагунин, С.В. Анализ использования доксициклина и линкомицина при колибактериозе и сальмонеллезе птиц / С.В. Лагунин // Ветеринарная практика. – 2005. – №4. – С. 9-21.

8. Новикова, О.Б. Проблема колибактериоза в птицеводстве / О.Б. Новикова, А.А. Бартенев // Современные тенденции развития науки и технологий. – 2015. – № 8. – С. 35-37.

9. Острая токсичность и сравнительная терапевтическая эффективность левофлоксацина при экспериментальном колибактериозе цыплят / А.Д. Мазур, Д.В. Юрин, В.Н. Скворцов, Ю.В. Тарасова // Международный вестник ветеринарии. – 2020. – № 3. – С. 89 – 93.

10. Скворцов В.Н., Заикина Е.Н., Юрин Д.В., Тарасова Ю.В. Сравнительная лечебно-профилактическая эффективность антимикробных препаратов при экспериментальном колибактериозе цыплят // Труды ВИЭВ, 2015.– Т.78.– С.363-368.

11. Таварджиев А.В., Ковалёв С.П. Аэрозольный метод профилактики и терапии колибактериоза птиц йодидом калия, его сочетанием с ампициллином // Вопросы нормативно-правового регулирования в ветеринарии. – 2020. – №1. – С.63-66.


Review

For citations:


Mazur A.D., Skvortsov V.N., Yurin D.V., Moiseeva A.A. Effectiveness of levofloxacin in experimental colibacillosis of laboratory animals and chickens. International Journal of Veterinary Medicine. 2021;(1):62-65. (In Russ.) https://doi.org/10.17238/issn2072-2419.2021.1.62

Views: 340


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2072-2419 (Print)